Summary of Classification and Labelling
Notified classification and labelling
General Information
954-128-5 |
1-[(6aS,9R)-3-chloro-1-fluoro-2-(2-fluoro-6-hydroxyphenyl)-9-methyl-5,6,6a,7,9,10-hexahydro-8H-pyrazino[1',2':5,6][1,5]oxazocino[4,3,2-de]quinazolin-8-yl]-2-propen-1-one |
|
Notified classification and labelling according to CLP criteria
STOT RE 2 |
H373
(adrenal glands,...)
(oral)
|
H373
|
|
GHS08 Wng
|
|
|
|
|
1 |
|
View details
|
Number of Aggregated Notifications: 1